Eriko Isogai

2.6k total citations
68 papers, 2.1k citations indexed

About

Eriko Isogai is a scholar working on Molecular Biology, Neurology and Periodontics. According to data from OpenAlex, Eriko Isogai has authored 68 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 17 papers in Neurology and 12 papers in Periodontics. Recurrent topics in Eriko Isogai's work include Neuroblastoma Research and Treatments (15 papers), Oral microbiology and periodontitis research (11 papers) and Vector-borne infectious diseases (7 papers). Eriko Isogai is often cited by papers focused on Neuroblastoma Research and Treatments (15 papers), Oral microbiology and periodontitis research (11 papers) and Vector-borne infectious diseases (7 papers). Eriko Isogai collaborates with scholars based in Japan, Nepal and United States. Eriko Isogai's co-authors include Akira Nakagawara, Hiroshi Isogai, Miki Ohira, Yohko Nakamura, Koichi Hirose, Hajime Kageyama, Hajime Takayasu, Yasuhiko Kaneko, Nobuhiro Fujii and Naoyuki Takada and has published in prestigious journals such as Journal of Clinical Investigation, PLoS ONE and Applied and Environmental Microbiology.

In The Last Decade

Eriko Isogai

67 papers receiving 2.1k citations

Peers

Countries citing papers authored by Eriko Isogai

Since Specialization

Citations

This map shows the geographic impact of Eriko Isogai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eriko Isogai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eriko Isogai more than expected).

Fields of papers citing papers by Eriko Isogai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eriko Isogai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eriko Isogai. The network helps show where Eriko Isogai may publish in the future.

Co-authorship network of co-authors of Eriko Isogai

This figure shows the co-authorship network connecting the top 25 collaborators of Eriko Isogai. A scholar is included among the top collaborators of Eriko Isogai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eriko Isogai. Eriko Isogai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Functional Polymorphism in Pak1–3′ Untranslated Region Alters Skin Tumor Susceptibility by Alternative Polyadenylation 2022 ·Journal of Investigative Dermatology ·Kazuhiro Okumura, (unknown), Eriko Isogai, (unknown), Yoshinori Hasegawa, Kimi Araki, Yuichi Wakabayashi	5
2	A Polymorphic Variant in p19Arf Confers Resistance to Chemically Induced Skin Tumors by Activating the p53 Pathway 2019 ·Journal of Investigative Dermatology ·(unknown), Kazuhiro Okumura, Eriko Isogai, Kimi Araki, Chizu Tanikawa, Koichi Matsuda, Takehiko Kamijo, Ryo Kominami, Yuichi Wakabayashi	4
3	Meis1 Regulates Epidermal Stem Cells and Is Required for Skin Tumorigenesis 2014 ·PLoS ONE ·Kazuhiro Okumura, (unknown), Eriko Isogai, (unknown), Tsuyoshi Hachiya, Yasubumi Sakakibara, Yoshinori Katsuragi, Satoshi Hirose, Ryo Kominami, Ryo Goitsuka, Takuro Nakamura, Yuichi Wakabayashi	27
4	Tat Pathway-Mediated Translocation of the Sec Pathway Substrate OprM, an Outer Membrane Subunit of the Resistance Nodulation Division Xenobiotic Extrusion Pumps, in <b><i>Pseudomonas Aeruginosa</i></b> 2013 ·Chemotherapy ·(unknown), (unknown), Eriko Isogai, Taiji Nakae, Hiroshi Yoneyama	2
5	Oncogenic LMO3 Collaborates with HEN2 to Enhance Neuroblastoma Cell Growth through Transactivation of Mash1 2011 ·PLoS ONE ·Eriko Isogai, Miki Ohira, Toshinori Ozaki, Shigeyuki Oba, Yohko Nakamura, Akira Nakagawara	38
6	LMO3 interacts with p53 and inhibits its transcriptional activity 2009 ·Biochemical and Biophysical Research Communications ·(unknown), Tomoki Yokochi, Eriko Isogai, Yohko Nakamura, Toshinori Ozaki, Akira Nakagawara	39
7	Novel risk stratification of patients with neuroblastoma by genomic signature, which is independent of molecular signature 2007 ·Oncogene ·Nobumoto Tomioka, Shinya Oba, Miki Ohira, Ankita Misra, Jane Fridlyand, Shin Ishii, Yohko Nakamura, Eriko Isogai, Takahiro Hirata, Yukiko Yoshida, Satoru Todo, Yasuhiko Kaneko, Donna G. Albertson, Daniel Pinkel, Burt G. Feuerstein, Akira Nakagawara	66
8	Bcl-2 is a key regulator for the retinoic acid-induced apoptotic cell death in neuroblastoma 2006 ·Oncogene ·Hidetaka Niizuma, Yohko Nakamura, Toshinori Ozaki, H. Nakanishi, Miki Ohira, Eriko Isogai, Hajime Kageyama, Masue Imaizumi, Akira Nakagawara	63
9	Increased expression of proapoptotic BMCC1, a novel gene with the BNIP2 and Cdc42GAP homology (BCH) domain, is associated with favorable prognosis in human neuroblastomas 2005 ·Oncogene ·Takeshi Machida, Tomoyuki Fujita, (unknown), Miki Ohira, Eriko Isogai, (unknown), Junko Hirato, Daihachiro Tomotsune, Takahiro Hirata, Maiko Fujimori, Wataru Adachi, Akira Nakagawara	52
10	Sensitivity of genera Porphyromonas and Prevotella to the bactericidal action of C‐terminal domain of human CAP18 and its analogues 2003 ·Oral Microbiology and Immunology ·Eriko Isogai, Hiroshi Isogai, (unknown), Koichi Hirose, Yusuke Kowashi, (unknown), Michimasa Hirata	23
11	Immunology and functional genomics of Beh�et's disease 2003 ·Cellular and Molecular Life Sciences ·Manfred Zierhut, Nobuhisa Mizuki, Shigeaki Ohno, Hidetoshi Inoko, (unknown), (unknown), Eriko Isogai	87
12	Induction of intestinal IgA and IgG antibodies preventing adhesion of verotoxin-producing Escherichia coli to Caco-2 cells by oral immunization with liposomes 2003 ·Letters in Applied Microbiology ·Tana Tana, Shinobu Watarai, Eriko Isogai, Keiji Oguma	16
13	Comparison of maximum bite force and dentate status between healthy and frail elderly persons 2001 ·Journal of Oral Rehabilitation ·Hiroko Miura, Satoru Watanabe, Eriko Isogai, Keita Miura	53
14	Demonstration of botulinum toxins of types B and D in soil samples from Zambia 2000 ·Annals of Tropical Medicine and Parasitology ·Tadahiro Karasawa, (unknown), Tsuneo Maegawa, Shinichi Nakamura, Bernard M. Hang’ombe, Eriko Isogai	4
15	Inductive effect of Porphyromonas gingivalis fimbriae on differentiation of human monocytic tumor cell line U937 1996 ·Oral Microbiology and Immunology ·Koichi Hirose, Eriko Isogai, (unknown), Hiroko Miura, (unknown)	6
16	Canine Lyme disease: clinical and serological evaluations in 21 dogs in Japan 1994 ·Veterinary Record ·(unknown), Eriko Isogai, Hiroshi Isogai, (unknown)	18
17	A new genomic species in Borrelia burgdorferi sensu lato isolated from Japanese ticks 1993 ·Research in Microbiology ·D. Postic, J Belfaiza, Eriko Isogai, Isabelle Saint Girons, Patrick A. D. Grimont, G. Baranton	53
18	Pelizaeus-Merzbacher disease: Cellular hypersensitivity to ultraviolet light 1992 ·Brain and Development ·Katsuo Sugita, (unknown), Jun‐ichi Takanashi, Nobuo Suzuki, Eriko Isogai, Hiroo Niimi	2
19	Serum factors responsible for unusual induction of plasminogen activator activity in tuberous sclerosis 1992 ·Journal of the Neurological Sciences ·Katsuo Sugita, Nobuo Suzuki, Eriko Isogai, Hiroo Niimi	10
20	BACTERIOLOGICAL STUDIES IN PLAQUE-SUSCEPTIBLE RATS 1984 ·Journal of Dental Research ·Eriko Isogai, Hiroshi Isogai, (unknown), (unknown), Nobutoshi Ito	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact